Target Validation Information
TTD ID T26623
Target Name Aldose reductase (AKR1B1)
Type of Target
Successful
Drug Potency against Target Epalrestat Drug Info IC50 = 280 nM [18]
Sulindac Drug Info IC50 = 100 nM [19]
(4-Methyl-2-oxo-2H-quinolin-1-yl)-acetic acid Drug Info IC50 = 6000 nM [16]
(6-Hydroxy-2-oxo-2H-quinolin-1-yl)-acetic acid Drug Info IC50 = 2400 nM [16]
(6-Methoxy-2-oxo-2H-quinolin-1-yl)-acetic acid Drug Info IC50 = 910 nM [16]
(8-Hydroxy-2-oxo-2H-quinolin-1-yl)-acetic acid Drug Info IC50 = 3300 nM [16]
2,3-dihydroxypropanal Drug Info IC50 = 10 nM [6]
2-(3,4-Dihydroxy-benzyl)-7-hydroxy-chromen-4-one Drug Info IC50 = 3140 nM [1]
2-(3,4-Dihydroxy-phenyl)-7-hydroxy-chromen-4-one Drug Info IC50 = 6520 nM [1]
2-(3-benzoyl-1H-pyrrol-1-yl)acetic acid Drug Info IC50 = 1970 nM [12]
2-(4-aminophenylsulfonamido)acetic acid Drug Info IC50 = 16000 nM [7]
2-Benzhydryl-7-hydroxy-chromen-4-one Drug Info IC50 = 10890 nM [1]
2-Benzyl-7-hydroxy-chromen-4-one Drug Info IC50 = 6610 nM [1]
3,5-dichlorosalicylic acid Drug Info IC50 = 11300 nM [9]
3-(3-Benzoyl-1H-pyrrol-1-yl)propanoic acid Drug Info IC50 = 9700 nM [12]
4-(3-Benzoyl-1H-pyrrol-1-yl)butanoic acid Drug Info IC50 = 6040 nM [12]
6,7-Dihydroxy-2-phenyl-chromen-4-one Drug Info IC50 = 3980 nM [1]
6-(1H-Indole-2-sulfonyl)-2H-pyridazin-3-one Drug Info IC50 = 590 nM [5]
6-(2-Bromo-benzenesulfonyl)-2H-pyridazin-3-one Drug Info IC50 = 210 nM [5]
6-(2-Chloro-benzenesulfonyl)-2H-pyridazin-3-one Drug Info IC50 = 170 nM [5]
6-(2-Fluoro-benzenesulfonyl)-2H-pyridazin-3-one Drug Info IC50 = 540 nM [5]
6-(3-Chloro-benzenesulfonyl)-2H-pyridazin-3-one Drug Info IC50 = 240 nM [5]
6-(4-Bromo-benzenesulfonyl)-2H-pyridazin-3-one Drug Info IC50 = 350 nM [5]
6-(4-Chloro-benzenesulfonyl)-2H-pyridazin-3-one Drug Info IC50 = 380 nM [5]
6-(4-Fluoro-benzenesulfonyl)-2H-pyridazin-3-one Drug Info IC50 = 474 nM [5]
6-(4-Methoxy-benzenesulfonyl)-2H-pyridazin-3-one Drug Info IC50 = 2000 nM [5]
6-(Benzofuran-2-sulfonyl)-2H-pyridazin-3-one Drug Info IC50 = 150 nM [5]
6-(Benzothiazole-2-sulfonyl)-2H-pyridazin-3-one Drug Info IC50 = 450 nM [5]
6-(Biphenyl-2-sulfonyl)-2H-pyridazin-3-one Drug Info IC50 = 2200 nM [5]
6-(Naphthalene-1-sulfonyl)-2H-pyridazin-3-one Drug Info IC50 = 150 nM [5]
6-(Naphthalene-2-sulfonyl)-2H-pyridazin-3-one Drug Info IC50 = 360 nM [5]
6-(Toluene-4-sulfonyl)-2H-pyridazin-3-one Drug Info IC50 = 1900 nM [5]
6-Benzenesulfonyl-2H-pyridazin-3-one Drug Info IC50 = 600 nM [5]
6-Hydroxy-2-(4-hydroxy-benzyl)-chromen-4-one Drug Info IC50 = 13120 nM [1]
6-Phenylmethanesulfonyl-2H-pyridazin-3-one Drug Info IC50 = 600 nM [5]
7-Hydroxy-2-(4-hydroxy-benzyl)-chromen-4-one Drug Info IC50 = 2500 nM [1]
7-Hydroxy-2-(4-methoxy-benzyl)-chromen-4-one Drug Info IC50 = 7010 nM [1]
7-Hydroxy-4-phenylcoumarin Drug Info IC50 = 2400 nM [15]
7-Hydroxy-6-nitro-2-phenyl-chromen-4-one Drug Info IC50 = 3870 nM [1]
APIGENIN Drug Info IC50 = 6670 nM [8]
Apigenin-7-O-beta-D-glucuronide Drug Info IC50 = 1280 nM [8]
Apigenin-7-O-beta-D-glucuronide methyl ester Drug Info IC50 = 9020 nM [8]
ASTRAGALIN Drug Info IC50 = 5090 nM [8]
Chrysin Drug Info IC50 = 7790 nM [14]
CONTIGOSIDE B Drug Info IC50 = 16000 nM [17]
daidzein Drug Info IC50 = 13630 nM [1]
EPALRESTATE Drug Info IC50 = 70 nM [8]
IMIRESTAT Drug Info IC50 = 5 nM [10]
Isorhamnetin 3,7-disulfate Drug Info IC50 = 1800 nM [17]
Isorhamnetin 3-O-rhamnoside Drug Info IC50 = 19000 nM [2]
KAEMPFEROL Drug Info IC50 = 1330 nM [8]
LIDORESTAT Drug Info IC50 = 5 nM [4]
MANGIFERIN Drug Info IC50 = 3200 nM [3]
MINALRESTAT Drug Info IC50 = 40 nM [9]
NSC-94258 Drug Info IC50 = 14650 nM [1]
O5-Acetyl-O7-nitrooxyethyl chrysin Drug Info IC50 = 860 nM [14]
O7-Nitrooxyethyl chrysin Drug Info IC50 = 490 nM [14]
PALBINONE Drug Info IC50 = 11400 nM [11]
Quercetin 3-O-neohesperidoside Drug Info IC50 = 18000 nM [2]
QUERCITRIN Drug Info IC50 = 160 nM [8]
Tamarixetin 3-glucoside-7-sulfate Drug Info IC50 = 5000 nM [17]
TINGENIN B Drug Info IC50 = 7000 nM [3]
TINGENONE Drug Info IC50 = 13000 nM [3]
TRIPTOCALLINE A Drug Info IC50 = 14000 nM [3]
ZOPOLRESTAT Drug Info IC50 = 60 nM [13]
References
REF 1 1-Benzopyran-4-one antioxidants as aldose reductase inhibitors. J Med Chem. 1999 Jun 3;42(11):1881-93.
REF 2 New flavonol oligoglycosides and polyacylated sucroses with inhibitory effects on aldose reductase and platelet aggregation from the flowers of Pru... J Nat Prod. 2002 Aug;65(8):1151-5.
REF 3 Structures of new friedelane-type triterpenes and eudesmane-type sesquiterpene and aldose reductase inhibitors from Salacia chinensis. J Nat Prod. 2003 Sep;66(9):1191-6.
REF 4 Discovery of 3-[(4,5,7-trifluorobenzothiazol-2-yl)methyl]indole-N-acetic acid (lidorestat) and congeners as highly potent and selective inhibitors ... J Med Chem. 2005 May 5;48(9):3141-52.
REF 5 A novel series of non-carboxylic acid, non-hydantoin inhibitors of aldose reductase with potent oral activity in diabetic rat models: 6-(5-chloro-3... J Med Chem. 2005 Oct 6;48(20):6326-39.
REF 6 Structural basis for the high all-trans-retinaldehyde reductase activity of the tumor marker AKR1B10. Proc Natl Acad Sci U S A. 2007 Dec 26;104(52):20764-9.
REF 7 Design and synthesis of N-(3,5-difluoro-4-hydroxyphenyl)benzenesulfonamides as aldose reductase inhibitors. Bioorg Med Chem. 2008 Apr 1;16(7):3926-32.
REF 8 Erigeroflavanone, a flavanone derivative from the flowers of Erigeron annuus with protein glycation and aldose reductase inhibitory activity. J Nat Prod. 2008 Apr;71(4):713-5.
REF 9 Correlation of binding constants and molecular modelling of inhibitors in the active sites of aldose reductase and aldehyde reductase. Bioorg Med Chem. 2009 Feb 1;17(3):1244-50.
REF 10 Spiro[fluoreneisothiazolidin]one dioxides: new aldose reductase and L-hexonate dehydrogenase inhibitors. J Med Chem. 1991 Nov;34(11):3229-34.
REF 11 Inhibitors of aldose reductase and formation of advanced glycation end-products in moutan cortex (Paeonia suffruticosa). J Nat Prod. 2009 Aug;72(8):1465-70.
REF 12 Design and synthesis of novel series of pyrrole based chemotypes and their evaluation as selective aldose reductase inhibitors. A case of bioisoste... Bioorg Med Chem. 2010 Mar 15;18(6):2107-2114.
REF 13 Chromene-3-carboxamide derivatives discovered from virtual screening as potent inhibitors of the tumour maker, AKR1B10. Bioorg Med Chem. 2010 Apr 1;18(7):2485-90.
REF 14 Synthesis, characterization and vasculoprotective effects of nitric oxide-donating derivatives of chrysin. Bioorg Med Chem. 2010 May 1;18(9):3020-5.
REF 15 6,7-Dihydroxy-4-phenylcoumarin as inhibitor of aldose reductase 2. Bioorg Med Chem Lett. 2010 Oct 1;20(19):5630-3.
REF 16 Synthesis and aldose reductase inhibitory activity of substituted 2-oxoquinoline-1-acetic acid derivatives. J Med Chem. 1986 Oct;29(10):2024-8.
REF 17 Effect of Polygonum hydropiper sulfated flavonoids on lens aldose reductase and related enzymes. J Nat Prod. 1996 Apr;59(4):443-5.
REF 18 Inhibitory activities of prenylated flavonoids from Sophora flavescens against aldose reductase and generation of advanced glycation endproducts. J Pharm Pharmacol. 2008 Sep;60(9):1227-36.
REF 19 Inhibition of lens and cataract aldose reductase by protein-bound anti-rheumatic drugs: salicylate, indomethacin, oxyphenbutazone, sulindac. Exp Eye Res. 1982 Jul;35(1):21-7.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.